<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hoffmann HH</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>Robertson Foundation</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH</funding><funding>Boehringer Ingelheim Fonds</funding><funding>NIGMS NIH HHS</funding><funding>BAWD Foundation</funding><pagination>133-148.e20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7954666</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>184(1)</volume><pubmed_abstract>Flaviviruses pose a constant threat to human health. These RNA viruses are transmitted by the bite of infected mosquitoes and ticks and regularly cause outbreaks. To identify host factors required for flavivirus infection, we performed full-genome loss of function CRISPR-Cas9 screens. Based on these results, we focused our efforts on characterizing the roles that TMEM41B and VMP1 play in the virus replication cycle. Our mechanistic studies on TMEM41B revealed that all members of the Flaviviridae family that we tested require TMEM41B. We tested 12 additional virus families and found that SARS-CoV-2 of the Coronaviridae also required TMEM41B for infection. Remarkably, single nucleotide polymorphisms present at nearly 20% in East Asian populations reduce flavivirus infection. Based on our mechanistic studies, we propose that TMEM41B is recruited to flavivirus RNA replication complexes to facilitate membrane curvature, which creates a protected environment for viral genome replication.</pubmed_abstract><journal>Cell</journal><pubmed_title>TMEM41B Is a Pan-flavivirus Host Factor.</pubmed_title><pmcid>PMC7954666</pmcid><funding_grant_id>T32 GM007250</funding_grant_id><funding_grant_id>R01 AI124690</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>P30 CA016087</funding_grant_id><funding_grant_id>R01 CA213448</funding_grant_id><funding_grant_id>R01AI124690</funding_grant_id><pubmed_authors>MacDonald MR</pubmed_authors><pubmed_authors>Yi S</pubmed_authors><pubmed_authors>Schneider WM</pubmed_authors><pubmed_authors>Jacobson E</pubmed_authors><pubmed_authors>Poirier JT</pubmed_authors><pubmed_authors>Miles LA</pubmed_authors><pubmed_authors>Hoffmann HH</pubmed_authors><pubmed_authors>McMullan LK</pubmed_authors><pubmed_authors>Razooky B</pubmed_authors><pubmed_authors>Schuster F</pubmed_authors><pubmed_authors>Rozen-Gagnon K</pubmed_authors><pubmed_authors>Rudin CM</pubmed_authors><pubmed_authors>Rice CM</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>TMEM41B Is a Pan-flavivirus Host Factor.</name><description>Flaviviruses pose a constant threat to human health. These RNA viruses are transmitted by the bite of infected mosquitoes and ticks and regularly cause outbreaks. To identify host factors required for flavivirus infection, we performed full-genome loss of function CRISPR-Cas9 screens. Based on these results, we focused our efforts on characterizing the roles that TMEM41B and VMP1 play in the virus replication cycle. Our mechanistic studies on TMEM41B revealed that all members of the Flaviviridae family that we tested require TMEM41B. We tested 12 additional virus families and found that SARS-CoV-2 of the Coronaviridae also required TMEM41B for infection. Remarkably, single nucleotide polymorphisms present at nearly 20% in East Asian populations reduce flavivirus infection. Based on our mechanistic studies, we propose that TMEM41B is recruited to flavivirus RNA replication complexes to facilitate membrane curvature, which creates a protected environment for viral genome replication.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2024-11-13T06:25:46.668Z</modification><creation>2021-03-18T08:36:38Z</creation></dates><accession>S-EPMC7954666</accession><cross_references><pubmed>33338421</pubmed><doi>10.1016/j.cell.2020.12.005</doi></cross_references></HashMap>